LVIA
NVO

Lind Value II ApS’s Novo Nordisk NVO Stock Holding History

Lind Value II ApS’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-299,144
Closed -$16.6M – 12
2025
Q3 		$16.6M Buy
299,144
+214,919
+255% +$12.6M 6.26% 6
2025
Q2 		$5.81M Buy
84,225
+68,939
+451% +$4.69M 2.56% 8
2025
Q1 		$1.06M Buy
+15,286
New +$1.26M 0.47% 9

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Lind Value II ApS's NVO Position: Q4 2025 in Review

Lind Value II ApS sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 299,144 shares — an estimated $16.6M sold.

Lind Value II ApS first reported a position in NVO in Q1 2025 and held it in 3 quarters. The position peaked at $16.6M in Q3 2025. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Lind Value II ApS reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Lind Value II ApS sold 299,144 Novo Nordisk shares in Q4 2025, an estimated $16.6M.
  • Lind Value II ApS first reported a position in Novo Nordisk in Q1 2025 and held it in 3 quarters.
  • Lind Value II ApS's Novo Nordisk position peaked at $16.6M in Q3 2025.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Lind Value II ApS's 13F filing for Q4 2025, filed 9 Feb 2026.